LILIFESTYLE
Lifestyle/August 5, 2026/3 min read

What Determines When Low Blood Sugar Becomes Severe? New Research Offers Clues

A study tracking people with Type 1 and Type 2 diabetes found that blood sugar variability and average glucose levels are key factors in whether a low blood sugar event stays mild or progresses to a more serious level.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

lifestyleexercisesleepstress

Key takeaways

  • Blood sugar variability—how much glucose swings up and down—is the strongest predictor of whether a low blood sugar event will become severe in Type 1 diabetes
  • Average blood sugar levels predict progression to severe lows in Type 2 diabetes, suggesting different risk patterns between the two conditions
  • People with Type 1 diabetes experienced more severe low blood sugar events overall compared to those with insulin-treated Type 2 diabetes
  • Understanding what drives progression from mild to severe lows could help identify people at higher risk and guide prevention strategies

Understanding Levels of Low Blood Sugar

When continuous glucose monitors (CGMs) detect low blood sugar, not all lows are created equal. Researchers distinguish between two levels: a mild low (Level 1) that drops below 3.9 mmol/L for at least 15 minutes, and a more serious low (Level 2) where blood sugar dips below 3.0 mmol/L for at least 15 minutes. A new study asked an important question: what determines whether a low blood sugar event stays at Level 1 or progresses to the more dangerous Level 2?

What the Research Looked At

Researchers analyzed data from the Hypo-METRICS study, which followed 212 people with Type 1 diabetes and 213 people with insulin-treated Type 2 diabetes over 10 weeks. All participants wore blinded continuous glucose monitors—devices that tracked blood sugar trends without showing real-time readings—along with fitness trackers. The study examined over 23,000 low blood sugar events to identify patterns and risk factors.

Blood Sugar Variability: The Key Factor in Type 1 Diabetes

The study found that in Type 1 diabetes, blood sugar variability—measured by a statistic called coefficient of variation—was the strongest predictor of whether a low blood sugar event would become severe. In simpler terms, people whose blood sugar swings more dramatically throughout the day were more likely to experience Level 2 lows. This suggests that managing the ups and downs of glucose, not just the average level, matters significantly for preventing severe hypoglycemia.

For context, people with Type 1 diabetes in the study had a 16% chance of their low blood sugar events progressing to Level 2, compared to 14% in those with Type 2 diabetes. Overall, people with Type 1 diabetes also tended to be younger (median age 49 versus 62) and were more likely to be female.

Average Blood Sugar: The Predictor in Type 2 Diabetes

In people with insulin-treated Type 2 diabetes, average blood sugar levels emerged as the strongest predictor of progression to Level 2 lows. Those with higher average glucose readings were more likely to experience severe low blood sugar events. This difference between Type 1 and Type 2 suggests that the underlying biology of the two conditions creates different risk patterns—a finding that could eventually inform personalized prevention approaches.

What This Means Moving Forward

This research doesn't offer a quick fix, but it does provide insight into which people might face higher risk of severe low blood sugar episodes. For Type 1 diabetes, understanding that blood sugar variability matters could guide conversations with diabetes care teams about management strategies. For Type 2 diabetes, focusing on average glucose control may be particularly relevant. Continuous glucose monitors, which were essential to this study, are tools that can help both patients and providers identify these patterns and adjust care accordingly. As always, anyone concerned about hypoglycemia risk should discuss their individual situation with their healthcare provider.

Evidence label

Source: Diabetes, obesity & metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.